Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations. (2017)
Attributed to:
Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10875-017-0433-3
PubMed Identifier: 28842866
Publication URI: http://europepmc.org/abstract/MED/28842866
Type: Journal Article/Review
Volume: 37
Parent Publication: Journal of clinical immunology
Issue: 7
ISSN: 0271-9142